transmedТрансляционная медицинаTranslational Medicine2311-44952410-5155Almazov National Medical Research Centre, Saint Petersburg, Russia10.18705/2311-4495-2019-6-1-17-26transmed-448Research ArticleОНКОЛОГИЧЕСКИЕ ЗАБОЛЕВАНИЯCANCERДИФФУЗИОННО-ВЗВЕШЕННАЯ МРТ И ПРОТОННАЯ МАГНИТНО-РЕЗОНАНСНАЯ СПЕКТРОСКОПИЯ В ДИАГНОСТИКЕ И ОЦЕНКЕ ЭФФЕКТИВНОСТИ ХИМИОЛУЧЕВОГО ЛЕЧЕНИЯ ОПУХОЛЕЙ ГОЛОВЫ И ШЕИ (ОБЗОР ЛИТЕРАТУРЫ)DIFFUSION-WEIGHTED MRI AND PROTON MAGNETIC RESONANCE SPECTROSCOPY IN THE DIAGNOSIS AND EVALUATION OF THE EFFECTIVENESS OF CHEMORADIOTHERAPY OF HEAD AND NECK TUMORS (THE LITERATURE REVIEW)СеменоваМ. Д.SemenovaM. D.

Семенова Мария Дмитриевна, ассистент, кафедра радиологии, хирургии и онкологии

Semenova Maria D., Assistant Professor, Department of Radiology, Surgery and Oncology

СокуренкоВ. П.SokurenkoV. P.

Сокуренко Валентина Петровна, д.м.н., заведующая радиологическим отделением № 4

Sokurenko Valentina P., MD, PhD, Head of the Radiological Department No. 4

СтанжевскийА. А.StanzhevskiyA. A.

 Станжевский Андрей Алексеевич, д.м.н., заместитель директора по научной работе

профессор курса радиологии кафедры лучевой диагностики и медицинской визуализации Института медицинского образования

Stanzhevskiy Andrey A., MD, PhD, Deputy Director for Scientific Work;

Professor, Department of Radiation Diagnostics and Medical Imaging, Institute of Medical Education

stanzhevsky@gmail.comМусВ. Ф.MusV. F.

Мус Виктор Федорович, главный научный сотрудник, отдел лучевых и комбинированных методов лечения опухолевых заболеваний

Mus Viktor F., Chief Researcher of the Department of Radiation and Combined Methods of Treating Tumor Diseases

Федеральное государственное бюджетное учреждение «Российский научный центр радиологии и хирургических технологий имени академика А. М. Гранова» Министерства здравоохранения Российской ФедерацииGranov Russian Research Center of Radiology and Surgical TechnologiesФедеральное государственное бюджетное учреждение «Российский научный центр радиологии и хирургических технологий имени академика А. М. Гранова» Министерства здравоохранения Российской Федерации; Федеральное государственное бюджетное учреждение «Национальный медицинский исследовательский центр имени В. А. Алмазова» Министерства здравоохранения Российской ФедерацииРоссияGranov Russian Research Center of Radiology and Surgical Technologies; Almazov National Medical Research CenterRussian Federation201906042019611726Copyright © Семенова М.Д., Сокуренко В.П., Станжевский А.А., Мус В.Ф., 20192019Семенова М.Д., Сокуренко В.П., Станжевский А.А., Мус В.Ф.Semenova M.D., Sokurenko V.P., Stanzhevskiy A.A., Mus V.F.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://transmed.almazovcentre.ru/jour/article/view/448

В обзоре представлен анализ современной литературы, посвященной диагностике опухолей головы и шеи, изучению их структурных и функциональных особенностей на базе использования технологий магнитно-резонансной томографии. Представлены данные о применении диффузионно-взвешенной МРТ и протонной магнитно-резонансной спектроскопии в диагностике, планировании и оценке эффективности лучевого и химиолучевого лечения различных новообразований головы и шеи.

The review presents an analysis of the modern literature on the diagnosis of head and neck tumors, as well as the study of their structural and functional features based on the use of magnetic resonance imaging technologies. The possibilities of diffusion-weighted MRI and proton magnetic resonance spectroscopy in the diagnosis, planning and evaluation of the effectiveness of radiation and sandwich therapy of head and neck cancer are presented in the review.

опухоли головы и шеимагнитно-резонансная томографиядиффузионно-взвешенная МРТпротонная магнитно-резонансная спектроскопияхимиолучевое лечениеhead and neck tumorsmagnetic resonance imagingdiffusion-weighted MRIproton magnetic resonance spectroscopychemoradiation treatmentНетReferencesKaprin AD, Starinskiy VV, Petrova GV. The State of Oncological Care to Population in Russia in 2017. M-: Gertcen MNIOI. 2018. p.236. In Russian. [Каприн А.Д., Старинский В.В., Петрова Г.В., Состояние онкологической помощи населению России в 2017 году. М.:МНИОИ им П. А. Герцена — филиала ФГБУ «НМИЦ радиологии» Минздрава России, 2018. с. 236].Yan K, Agrawal N, Gooi Z. Head and Neck Masses. Med Clin North Am. 2018 Nov;102(6):1013-1025. doi: 10.1016/j.mcna2.Braunschweig T, Lewandrowski A, Smeets D et al. Squamous Cell Carcinoma of the Head and Neck: New Avenues of Treatment? Head and Neck Tumors. 2013;3:4– 10. In Russian [Брауншвейг Т., Левандровски А., Смеетс Д. и др. Плоскоклеточный рак головы и шеи: новые перспективы лечения? Опухоли головы и шеи. 2013;3:4–10].Curado MP, Boyle P Epidemiology of head and neck squamous cell carcinoma not related to tobacco or alcohol. Curr Opin Oncol 2013;25(3):229–34.Brennan JA, Boyle JO, Koch WM et al. Association Between Cigarette Smoking and Mutation of the p53 Gene in Squamous-cell Carcinoma of the Head and Neck. N Engl J Med. 1995;332(11):712–717Dai YL, King AD State of the art MRI in head and neck cancer Clin Radiol. 2018 Jan;73(1):45-59. doi: 10.1016/j.crad.2017.05.020. Epub 2017 Jun 24.Denaro N, Merlano MC, Russi EG. Follow-up in Head and Neck Cancer: Do More Does It Mean Do Better? A Systematic Review and Our Proposal Based on Our Experience. Clin Exp Otorhinolaryngol. 2016;9(4):287–297.Ahn SJ, Choi SH, Kim YJ, et al. Histogram analysis of apparent diffusion coefficient map of standard and high B-value diffusion MR imaging in head and neck squamous cell carcinoma: a correlation study with histological grade. Acad Radiol 2012;19(10):1233-40.Quintero K, Giraldo GA, Uribe ML et al. Human Papillomavirus Types in Cases of Squamous Cell Carcinoma of Head and Neck in Colombia. Braz J Otorhinolaryngol. 2013;79(3):375–381.Hwang I, Choi SH, Kim YJ, et al. Differentiation of recurrent tumor and posttreatment changes in head and neck squamous cell carcinoma: application of high b-value diffusion-weighted imaging. AJNR Am J Neuroradiol 2013;34(12):2343-8.Curado MP, Boyle P. Epidemiology of Head and Neck Squamous Cell Carcinoma Not Related to Tobacco or Alcohol. Curr Opin Oncol. 2013;25(3):229–234.Yun TJ, Kim JH, Kim KH, et al. Head and neck squamous cell carcinoma: differentiation of histologic grade with standard- and high-b-value diffusion-weighted MRI. Head Neck 2013;35(5):626-31.Van Monsjou HS, van Velthuysen ML, van den Brekel MW et al. Human Papillomavirus Status in Young Patients with Head and Neck Squamous Cell Carcinoma. Int J Cancer. 2012;130(8):1806–1812.Ryoo I, Kim JH, Choi SH, et al. Squamous cell carcinoma of the head and neck: comparison of diffusion-weighted MRI at b-values of 1,000 and 2,000 s/mm2 to predict response to induction chemotherapy. Magn Reson Med Sci 2015;14(4):337-45.Smeets D, Ertmer K, Braunschweig T et al. HPV in Squamous Epithelial Lesions of the Head and Neck: Different Affection of Different Tumors. Tumors of the Head and Neck. 2011;1:61–65. In Russian [Смеетс Д., Эртмер К., Брауншвейг Т. и др. Роль вируса папилломы человека (ВПЧ) при различных локализациях плоскоклеточного рака головы и шеи. Опухоли головы и шеи. 2011;1:61–65].Acampora A, Manzo G, Fenza G, et al. High b-value diffusion MRI to differentiate recurrent tumors from posttreatment changes in head and neck squamous cell carcinoma: a single center prospective study. Biomed Res Int 2016;2016:2865169Thomas J, Primeaux T. Is p16 Immunohistochemistry a More Cost-effective Method for Identification of Human Papilloma Virus-associated Head and Neck Squamous Cell Carcinoma? Ann Diagn Pathol. 2012;16(2):91–99.Wang J, Takashima S, Takayama F, et al. Head and neck lesions: characterization with diffusion-weighted echo-planar MR imaging. Radiology 2001;220(3):621-30.Dai YL, King AD. State of the Art MRI in Head and Neck Cancer. Clin Radiol. 2018;73(1):45–59.Thoeny HC, De Keyzer F, King AD. Diffusion-weighted MR imaging in the head and neck. Radiology 2012;263(1):19-32.Korostyshevskaya AM, Savelov AA, Tsydenova DV et al. Quantitative Analysis of Perinatal Brain Maturation Using Deffusion-weighted MRI. Bulletin of Novosib State Univ. Series: Biology, Clinical Medicine= Vestn. Novosib. gos. un-ta. Serija: Biologija, klinicheskaja medicina. 2015;13(4):27–32. In Russian [Коростышевская А. М., Савелов А. А., Цыденова Д. В. и др. Количественный анализ структурной зрелости головного мозга плода, по данным диффузионно-взвешенной МРТ. Вестн. Новосиб. гос. ун-та. Серия: Биология, клиническая медицина. 2015;13(4):27–32].Abdel Razek AA, Nada N. Role of diffusion-weighted MRI in differentiation of masticator space malignancy from infection. Dentomaxillofac Radiol 2013;42(4):20120183.Ahn SJ, Choi SH, Kim YJ et al. Histogram Analysis of Apparent Diffusion Coefficient Map of Standard and High B-value Diffusion MR Imaging in Head and Neck Squamous Cell Carcinoma: a Correlation Study with Histological Grade. Acad Radiol. 2012;19(10):1233–1240.Koc O, Paksoy Y, Erayman I, et al. Role of diffusion weighted MR in the discrimination diagnosis of the cystic and/or necrotic head and neck lesions. Eur J Radiol 2007;62(2):205-13.Hwang I, Choi SH, Kim YJ et al. Differentiation of Recurrent Tumor and Posttreatment Canges in Head and Neck Squamous Cell Carcinoma: Application of High B-value Diffusion-weighted Imaging. AJNR Am J Neuroradiol. 2013;34(12):2343–2348.King AD, Yeung DK, Ahuja AT, et al. Salivary gland tumors at in vivo proton MR spectroscopy. Radiology 2005;237(2):563-9.Yun TJ, Kim JH, Kim KH et al. Head and Neck Squamous Cell Carcinoma: Differentiation of Histologic Grade with Standard- and High-b-value Diffusion-weighted MRI. Head Neck. 2013;35(5):626–631.Salama AA, El-Barbary AH, Mlees MA, et al. Value of apparent diffusion coefficient and magnetic resonance spectroscopy in the identification of various pathological subtypes of parotid gland tumors. Egypt J Radiol Nucl Med 2015;46(1):45-52.Ryoo I, Kim JH, Choi SH et al. Squamous Cell Carcinoma of the Head and Neck: Comparison of Diffusionweighted MRI at B-values of 1,000 and 2,000 s/mm(2) to Predict Response to Induction Chemotherapy. Magn Reson Med Sci. 2015;14(4):337–345.Chen L, Xu J, Bao J, et al. Diffusion-weighted MRI in differentiating malignant from benign thyroid nodules: a meta-analysis. BMJ Open 2016;6(1):008413.Acampora A, Manzo G, Fenza G et al. High B-value Diffusion MRI to Differentiate Recurrent Tumors from Posttreatment Changes in Head and Neck Squamous Cell Carcinoma: a Single Center Prospective Study. Biomed Res Int. 2016;2016:2865169.Maeda M, Kato H, Sakuma H, et al. Usefulness of the apparent diffusion coefficient in line scan diffusion-weighted imaging for distinguishing between squamous cell carcinomas and malignant lymphomas of the head and neck. AJNR 2005;26(5):1186-92.Wang J, Takashima S, Takayama F et al. Head and Neck Lesions: Characterization with Diffusion-weighted Echo-planar MR Imaging. Radiology. 2001;220(3):621–630.Ichikawa Y, Sumi M, Sasaki M, et al. Efficacy of diffusion-weighted imaging for the differentiation between lymphomas and carcinomas of the nasopharynx and oropharynx: correlations of apparent diffusion coefficients and histologic features. AJNR Am J Neuroradiol 2012;33(4):761-6.Thoeny HC, De Keyzer F, King AD. Diffusionweighted MR Imaging in the Head and Neck. Radiology. 2012;263(1):19–32.Sumi M, Nakamura T. Head and neck tumours: combined MRI assessment based on IVIM and TIC analyses for the differentiation of tumors of different histological types. Eur Radiol 2014;24(1):223-31Abdel Razek AA, Nada N. Role of Diffusionweighted MRI in Differentiation of Masticator Space Malignancy from Infection. Dentomaxillofac Radiol. 2013;42(4):20120183.Kato H, Kanematsu M, Kato Z, et al. Necrotic cervical nodes: usefulness of diffusion-weighted MR imaging in the differentiation of suppurative lymphadenitis from malignancy. Eur J Radiol 2013;82(1):28-35.Koc O, Paksoy Y, Erayman I et al. Role of Diffusion Weighted MR in the Discrimination Diagnosis of the Cystic and/or Necrotic Head and Neck Lesions. Eur J Radiol. 2007;62(2):205–213.Zhang Y, Chen J, Shen J, et al. Apparent diffusion coefficient values of necrotic and solid portion of lymph nodes: differential diagnostic value in cervical lymphadenopathy. Clin Radiol 2013;68(3):224-31.Kato H, Kanematsu M, Kato Z et al. Necrotic Cervical Nodes: Usefulness of Diffusion-weighted MR Imaging in the Differentiation of Suppurative Lymphadenitis from Malignancy. Eur J Radiol. 2013;82(1):e28–35.Holzapfel K, Duetsch S, Fauser C, et al. Value of diffusion-weighted MR imaging in the differentiation between benign and malignant cervical lymph nodes. Eur J Radiol 2009;72(3):381-7.Zhang Y, Chen J, Shen J et al. Apparent Diffusion Coefficient Values of Necrotic and Solid Portion of Lymph Nodes: Differential Diagnostic Value in Cervical Lymphadenopathy. Clin Radiol. 2013;68(3):224–231.King AD, Ahuja AT, Yeung DK, et al. Malignant cervical lymphadenopathy: diagnostic accuracy of diffusion-weighted MR imaging. Radiology 2007;245(3):806-13.King AD, Yeung DK, Ahuja AT et al. Salivary Gland Tumors at In Vivo Proton MR Spectroscopy. Radiology. 2005;237(2):563–569.Vandecaveye V, De Keyzer F, Vander Poorten V, et al. Head and neck squamous cell carcinoma: value of diffusion-weighted MR imaging for nodal staging. Radiology 2009;251(1):134-46.Salama AA, El-Barbary AH, Mlees MA et al. Value of Apparent Diffusion Coefficient and Magnetic Resonance Spectroscopy in the Identification of Various Pathological Subtypes of Parotid Gland Tumors. Egypt J Radiol Nucl Med. 2015;46(1):45–52.De Bondt RB, Hoeberigs MC, Nelemans PJ, et al. Diagnostic accuracy and additional value of diffusion-weighted imaging for discrimination of malignant cervical lymph nodes in head and neck squamous cell carcinoma. Neuroradiology 2009;51(3):183-92.Chen L, Xu J, Bao J et al. Diffusion-weighted MRI in Differentiating Malignant from Benign Thyroid Nodules: a Meta-analysis. BMJ Open. 2016;6(1):e008413.Musio D, Bulzonetti N, Maghella F, et al. Target volume delineation based on diffusion-weighted magnetic resonance imaging for locally advanced head and neck cancer. Anticancer Res 2016;36(8):4181-5.Holzapfel K, Duetsch S, Fauser C et al. Value of Diffusion-weighted MR Imaging in the Differentiation Between Benign and Malignant Cervical Lymph Nodes. Eur J Radiol. 2009;72(3):381–387.Kauppinen RA, Peet AC Using magnetic resonance imaging and spectroscopy in cancer diagnostics and monitoring: Preclinical and clinical approaches Cancer Biol Ther. 2011 Oct 15; 12(8): 665–679. doi: 10.4161/cbt.12.8.18137Maeda M, Kato H, Sakuma H et al. Usefulness of the Apparent Diffusion Coefficient in Line Scan Diffusionweighted Imaging for Distinguishing Between Squamous Cell Carcinomas and Malignant Lymphomas of the Head and Neck. AJNR Am J Neuroradiol. 2005;26(5):1186–1192.Abdel Razek AA, Poptani H.MR spectroscopy of head and neck cancer.Eur J Radiol. 2013 Jun;82(6):982-9. doi: 10.1016/j.ejrad.2013.01.025.King AD, Ahuja AT, Yeung DK et al. Malignant Cervical Lymphadenopathy: Diagnostic Accuracy of Diffusion-weighted MR Imaging. Radiology. 2007;245(3):806–813.Yeung DK, Fong KY, Chan QC, et al. Chemical shift imaging in the head and neck at 3T: initial results. J Magn Reson Imaging 2010;32(5):1248-54.Ichikawa Y, Sumi M, Sasaki M et al. Efficacy of Diffusion-weighted Imaging for the Differentiation Between Lymphomas and Carcinomas of the Nasopharynx and Oropharynx: Correlations of Apparent Diffusion Coefficients and Histologic Features. AJNR Am J Neuroradiol. 2012;33(4):761–766.Yuan J, Chen S, King AD, et al. Amide proton transfer-weighted imaging of the head and neck at 3 T: a feasibility study on healthy human subjects and patients with head and neck cancer. NMR Biomed 2014;27(10):1239-47.Sumi M, Nakamura T. Head and Neck Tumours: Combined MRI Assessment Based on IVIM and TIC Analyses for the Differentiation of Tumors of Different Histological Types. Eur Radiol. 2014;24(1):223–231.Wang J, Hwang K, Fuller C, et al. SU-E-J-225: CEST imaging in head and neck cancer patients. Med Phys 2015;42(6). 3317-3317Vandecaveye V, De Keyzer F, Vander Poorten V et al. Head and Neck Squamous Cell Carcinoma: Value of Diffusion-weighted MR Imaging for Nodal Staging. Radiology. 2009;251(1):134–146.Bisdas S, Fetscher S, Feller AC, et al. Primary B cell lymphoma of the sphenoid sinus: CT and MRI characteristics with correlation to perfusion and spectroscopic imaging features. Eur Arch Otorhinolaryngol 2007;264(10):1207-13.Abdel Razek AA, Soliman NY, Elkhamary S et al. Role of Diffusion-weighted MR Imaging in Cervical Lymphadenopathy. Eur Radiol. 2006;16(7):1468–1477.King AD, Yeung DK, Ahuja AT, et al. Human cervical lymphadenopathy: evaluation with in vivo 1 H-MRS at 1.5 T. Clin Radiol 2005;60(5):592-8.de Bondt RB, Hoeberigs MC, Nelemans PJ et al. Diagnostic Accuracy and Additional Value of Diffusionweighted Imaging for Discrimination of Malignant Cervical Lymph Nodes in Head and Neck Squamous Cell Carcinoma. Neuroradiology. 2009;51(3):183–192.Yu Q, Yang J, Wang P, et al. Preliminary assessment of benign maxillofacial and neck lesions with in vivo single-voxel 1 H magnetic resonance spectroscopy. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2007;104(2):264-70.Lee MC, Tsai HY, Chuang KS et al. Prediction of Nodal Metastasis in Head and Neck Cancer Using a 3T MRI ADC Map. AJNR Am J Neuroradiol. 2013;34(4):864–869.Galban CJ, Mukherji SK, Chenevert TL, et al. A feasibility study of parametric response map analysis of diffusion-weighted magnetic resonance imaging scans of head and neck cancer patients for providing early detection of therapeutic efficacy. Transl Oncol 2009;2(3):184-90.Barchetti F, Pranno N, Giraldi G et al. The Role of 3 Tesla Diffusion-weighted Imaging in the Differential Diagnosis of Benign Versus Malignant Cervical Lymph Nodes in Patients with Head and Neck Squamous Cell Carcinoma. Biomed Res Int. 2014;2014:532095.Vandecaveye V, Dirix P, De Keyzer F, et al. Predictive value of diffusion weighted magnetic resonance imaging during chemoradiotherapy for head and neck squamous cell carcinoma. Eur Radiol 2010;20(7):1703-14.Zhong J, Lu Z, Xu L et al. The Diagnostic Value of Cervical Lymph Node Metastasis in Head and Neck Squamous Carcinoma by Using Diffusion-weighted Magnetic Resonance Imaging and Computed Tomography Perfusion. Biomed Res Int. 2014;2014:260859.Chen Y, Liu X, Zheng D, et al. Diffusion-weighted magnetic resonance imaging for early response assessment of chemoradiotherapy in patients with nasopharyngeal carcinoma. Magn Reson Imaging 2014;32(6):630-7.De Felice F, Musio D, Bulzonetti N et al. Target Volume Delineation Based on Diffusion-weighted Magnetic Resonance Imaging for Locally Advanced Head and Neck Cancer. Anticancer Res. 2016;36(8):4181–4185.Martins EB, Chojniak R, Kowalski LP, et al. Diffusion-weighted MRI in the assessment of early treatment response in patients with squamouscell carcinoma of the head and neck: comparison with morphological and PET/CT findings. PLoS One 2015;10(11):0140009.Baba Y, Furusawa M, Murakami R et al. Role of Dynamic MRI in the Evaluation of Head and Neck Cancers Treated with Radiation Therapy. Int J Radiat Oncol Biol Phys. 1997;37(4):783–787.Wong KH, Panek R, Welsh L, et al. The predictive value of early assessment after 1 cycle of induction chemotherapy with 18F-FDG PET/ CT and diffusion-weighted MRI for response to radical chemoradiotherapy in head and neck squamous cell carcinoma. J Nucl Med 2016;57(12):1843-50.Korostishevskaya AM. Proton MR Spectroscopy Diagnostic Value (Review of Perspective Fields). Medical imaging. 2007;3:130–143. In Russian [Коростышевская А. М. Диагностические возможности магнитно-резонансной спектроскопии (обзор перспективных направлений) Медицинская визуализация. 2007;3:130–143].King AD, Chow KK, Yu KH, et al. Head and neck squamous cell carcinoma: diagnostic performance of diffusion-weighted MR imaging for the prediction of treatment response. Radiology 2013;266(2):5318.Sinson G, Bagley LJ, Cecil KM et al. Magnetization Transfer Imaging and Proton MR Spectroscopy in the Evaluation of Axonal Injury: Correlation with Clinical Outcome after Traumatic Brain Injury. AJNR Am J Neuroradiol. 2001;22(1):143–151.King AD, Mo FK, Yu KH, et al. Squamous cell carcinoma of the head and neck: diffusion-weighted MR imaging for prediction and monitoring of treatment response. Eur Radiol 2010;20(9):2213-20.Mascalchi M, Cosottini M, Lolli F et al. Proton MR Spectroscopy of the Cerebellum and Pons in Patients with Degenerative Ataxia. Radiology. 2002;223(2):371– 378.Abdel Razek AA, Kandeel AY, Soliman N, et al. Role of diffusionweighted echo-planar MR imaging in differentiation of residual or recurrent head and neck tumors and posttreatment changes. AJNR Am J Neuroradiol 2007;28(6):1146-52.Bogdanov AV. Proton MR Spectroscopy (Review). Bulletin of KRSU. 2016;16(3):151–156. In Russian [Богданов А. В. Магнитно-резонансная спектроскопия (обзор литературы). Вестник КРСУ. 2016;16(3):151–156].King AD, Keung CK, Yu KH, et al. T2-weighted MR imaging early after chemoradiotherapy to evaluate treatment response in head and neck squamous cell carcinoma. AJNR Am J Neuroradiol 2013;34(6):1237-41.Abdel Razek AA, Poptani H. MR Spectroscopy of Head and Neck Cancer. Eur J Radiol. 2013;82(6):982–989.Abdel Razek AA, Poptani H. MR Spectroscopy of Head and Neck Cancer. Eur J Radiol. 2013;82(6):982–989.Yeung DK, Fong KY, Chan QC et al. Chemical Shift Imaging in the Head and Neck at 3T: Initial Results. J Magn Reson Imaging. 2010;32(5):1248–1254.Yeung DK, Fong KY, Chan QC et al. Chemical Shift Imaging in the Head and Neck at 3T: Initial Results. J Magn Reson Imaging. 2010;32(5):1248–1254.Yuan J, Chen S, King AD et al. Amide Proton Transfer-weighted Imaging of the Head and Neck at 3 T: a Feasibility Study on Healthy Human Subjects and Patients with Head and Neck Cancer. NMR Biomed. 2014;27(10):1239–1247.Yuan J, Chen S, King AD et al. Amide Proton Transfer-weighted Imaging of the Head and Neck at 3 T: a Feasibility Study on Healthy Human Subjects and Patients with Head and Neck Cancer. NMR Biomed. 2014;27(10):1239–1247.Wang J, Hwang K, Fuller C et al. SU-E-J-225: CEST Imaging in Head and Neck Cancer Patients. Med Phys. 2015;42(6):3317.Wang J, Hwang K, Fuller C et al. SU-E-J-225: CEST Imaging in Head and Neck Cancer Patients. Med Phys. 2015;42(6):3317.King AD, Yeung DK, Ahuja AT et al. Human Cervical Lymphadenopathy: Evaluation with In Vivo 1 H-MRS at 1.5 T. Clin Radiol. 2005;60(5):592–598.King AD, Yeung DK, Ahuja AT et al. Human Cervical Lymphadenopathy: Evaluation with In Vivo 1 H-MRS at 1.5 T. Clin Radiol. 2005;60(5):592–598.Bisdas S, Fetscher S, Feller AC et al. Primary B Cell Lymphoma of the Sphenoid Sinus: CT and MRI Characteristics with Correlation to Perfusion and Spectroscopic Imaging Features. Eur Arch Otorhinolaryngol. 2007;264(10):1207–1213.Bisdas S, Fetscher S, Feller AC et al. Primary B Cell Lymphoma of the Sphenoid Sinus: CT and MRI Characteristics with Correlation to Perfusion and Spectroscopic Imaging Features. Eur Arch Otorhinolaryngol. 2007;264(10):1207–1213.Yu Q, Yang J, Wang P et al. Preliminary Assessment of Benign Maxillofacial and Neck Lesions with In Vivo Single-voxel 1H Magnetic Resonance Spectroscopy. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2007;104(2):264–270.Yu Q, Yang J, Wang P et al. Preliminary Assessment of Benign Maxillofacial and Neck Lesions with In Vivo Single-voxel 1H Magnetic Resonance Spectroscopy. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2007;104(2):264–270.Brandao LA, Castillo M. Adult Brain Tumors: Clinical Applications of Magnetic Resonance Spectroscopy. Neuroimaging Clin N Am. 2013;23(3):527–555.Brandao LA, Castillo M. Adult Brain Tumors: Clinical Applications of Magnetic Resonance Spectroscopy. Neuroimaging Clin N Am. 2013;23(3):527–555.Galban CJ, Mukherji SK, Chenevert TL et al. A Feasibility Study of Parametric Response Map Analysis of Diffusion-weighted Magnetic Resonance Imaging Scans of Head and Neck Cancer Patients for Providing Early Detection of Therapeutic Efficacy. Transl Oncol. 2009;2(3):184–190.Galban CJ, Mukherji SK, Chenevert TL et al. A Feasibility Study of Parametric Response Map Analysis of Diffusion-weighted Magnetic Resonance Imaging Scans of Head and Neck Cancer Patients for Providing Early Detection of Therapeutic Efficacy. Transl Oncol. 2009;2(3):184–190.Vandecaveye V, Dirix P, De Keyzer F et al. Predictive Value of Diffusion-weighted Magnetic Resonance Imaging During Chemoradiotherapy for Head and Neck Squamous Cell Carcinoma. Eur Radiol. 2010;20(7):1703–1714.Vandecaveye V, Dirix P, De Keyzer F et al. Predictive Value of Diffusion-weighted Magnetic Resonance Imaging During Chemoradiotherapy for Head and Neck Squamous Cell Carcinoma. Eur Radiol. 2010;20(7):1703–1714.Chen Y, Liu X, Zheng D et al. Diffusionweighted Magnetic Resonance Imaging for Early Response Assessment of Chemoradiotherapy in Patients with Nasopharyngeal Carcinoma. Magn Reson Imaging. 2014;32(6):630–637.Chen Y, Liu X, Zheng D et al. Diffusionweighted Magnetic Resonance Imaging for Early Response Assessment of Chemoradiotherapy in Patients with Nasopharyngeal Carcinoma. Magn Reson Imaging. 2014;32(6):630–637.Martins EB, Chojniak R, Kowalski LP et al. Diffusion-weighted MRI in the Assessment of Early Reatment Response in Patients with Squamous-cell Carcinoma of the Head and Neck: Comparison with Morphological and PET/CT Findings. PLoS One. 2015;10(11):e0140009.Martins EB, Chojniak R, Kowalski LP et al. Diffusion-weighted MRI in the Assessment of Early Reatment Response in Patients with Squamous-cell Carcinoma of the Head and Neck: Comparison with Morphological and PET/CT Findings. PLoS One. 2015;10(11):e0140009.Wong KH, Panek R, Welsh L et al. The Predictive Value of Early Assessment after 1 Cycle of Induction Chemotherapy with 18F-FDG PET/CT and Diffusionweighted MRI for Response to Radical Chemoradiotherapy in Head and Neck Squamous Cell Carcinoma. J Nucl Med. 2016;57(12):1843–1850.Wong KH, Panek R, Welsh L et al. The Predictive Value of Early Assessment after 1 Cycle of Induction Chemotherapy with 18F-FDG PET/CT and Diffusionweighted MRI for Response to Radical Chemoradiotherapy in Head and Neck Squamous Cell Carcinoma. J Nucl Med. 2016;57(12):1843–1850.King AD, Chow KK, Yu KH et al. Head and Neck Squamous Cell Carcinoma: Diagnostic Performance of Diffusion-weighted MR Imaging for the Prediction of Treatment Response. Radiology. 2013;266(2):531–538.King AD, Chow KK, Yu KH et al. Head and Neck Squamous Cell Carcinoma: Diagnostic Performance of Diffusion-weighted MR Imaging for the Prediction of Treatment Response. Radiology. 2013;266(2):531–538.King AD, Mo FK, Yu KH et al. Squamous Cell Carcinoma of the Head and Neck: Diffusion-weighted MR Imaging for Prediction and Monitoring of Treatment Response. Eur Radiol. 2010;20(9):2213–2220.King AD, Mo FK, Yu KH et al. Squamous Cell Carcinoma of the Head and Neck: Diffusion-weighted MR Imaging for Prediction and Monitoring of Treatment Response. Eur Radiol. 2010;20(9):2213–2220.Abdel Razek AA, Kandeel AY, Soliman N et al. Role of Diffusion-weighted Echo-planar MR Imaging in Differentiation of Residual or Recurrent Head and Neck Tumors and Posttreatment Changes. AJNR Am J Neuroradiol. 2007;28(6):1146–1152.Abdel Razek AA, Kandeel AY, Soliman N et al. Role of Diffusion-weighted Echo-planar MR Imaging in Differentiation of Residual or Recurrent Head and Neck Tumors and Posttreatment Changes. AJNR Am J Neuroradiol. 2007;28(6):1146–1152.Vandecaveye V, De Keyzer F, Nuyts S et al. Detection of Head and Neck Squamous Cell Carcinoma with Diffusion Weighted MRI after (chemo) Radiotherapy: Correlation Between Radiologic and Histopathologic Findings. Int J Radiat Oncol Biol Phys. 2007;67(4):960–971.Vandecaveye V, De Keyzer F, Nuyts S et al. Detection of Head and Neck Squamous Cell Carcinoma with Diffusion Weighted MRI after (chemo) Radiotherapy: Correlation Between Radiologic and Histopathologic Findings. Int J Radiat Oncol Biol Phys. 2007;67(4):960–971.Gouhar GK, El-Hariri MA. Feasibility of Diffusion Weighted MR Imaging in Differentiating Recurrent Laryngeal Carcinoma from Radionecrosis. Egypt J Radiol Nucl Med. 2011;42(2):169–175.Gouhar GK, El-Hariri MA. Feasibility of Diffusion Weighted MR Imaging in Differentiating Recurrent Laryngeal Carcinoma from Radionecrosis. Egypt J Radiol Nucl Med. 2011;42(2):169–175.Vandecaveye V, Dirix P, De Keyzer F et al. Diffusion-weighted Magnetic Resonance Imaging Early after Chemoradiotherapy to Monitor Treatment Response in Head-and-neck Squamous Cell Carcinoma. Int J Radiat Oncol Biol Phys. 2012;82(3):1098–1107.Vandecaveye V, Dirix P, De Keyzer F et al. Diffusion-weighted Magnetic Resonance Imaging Early after Chemoradiotherapy to Monitor Treatment Response in Head-and-neck Squamous Cell Carcinoma. Int J Radiat Oncol Biol Phys. 2012;82(3):1098–1107.Tshering Vogel DW, Zbaeren P, Geretschlaeger A et al. Diffusion-weighted MR Imaging Including Biexponential Fitting for the Detection of Recurrent or Residual Tumour after (Chemo)radiotherapy for Laryngeal and Hypopharyngeal Cancers. Eur Radiol. 2013;23(2):562–569.Tshering Vogel DW, Zbaeren P, Geretschlaeger A et al. Diffusion-weighted MR Imaging Including Biexponential Fitting for the Detection of Recurrent or Residual Tumour after (Chemo)radiotherapy for Laryngeal and Hypopharyngeal Cancers. Eur Radiol. 2013;23(2):562–569.Ravanelli M, Farina D, Rizzardi P et al. MR with Surface Coils in the Follow-up after Endoscopic Laser Resection for Glottic Squamous Cell Carcinoma: Feasibility and Diagnostic Accuracy. Neuroradiology. 2013;55(2):225– 232.Ravanelli M, Farina D, Rizzardi P et al. MR with Surface Coils in the Follow-up after Endoscopic Laser Resection for Glottic Squamous Cell Carcinoma: Feasibility and Diagnostic Accuracy. Neuroradiology. 2013;55(2):225– 232.King AD, Keung CK, Yu KH et al. T2-weighted MR Imaging Early after Chemoradiotherapy to Evaluate Treatment Response in Head and Neck Squamous Cell Carcinoma. AJNR Am J Neuroradiol. 2013;34(6):1237– 1241.King AD, Keung CK, Yu KH et al. T2-weighted MR Imaging Early after Chemoradiotherapy to Evaluate Treatment Response in Head and Neck Squamous Cell Carcinoma. AJNR Am J Neuroradiol. 2013;34(6):1237– 1241.

The authors declare that there are no conflicts of interest present.